Logo image of CGBD

CARLYLE SECURED LENDING INC (CGBD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CGBD - US8722801029 - Common Stock

12.55 USD
-0.1 (-0.79%)
Last: 12/1/2025, 8:00:00 PM
12.55 USD
0 (0%)
After Hours: 12/1/2025, 8:00:00 PM
Fundamental Rating

4

Taking everything into account, CGBD scores 4 out of 10 in our fundamental rating. CGBD was compared to 238 industry peers in the Capital Markets industry. Both the profitability and the financial health of CGBD get a neutral evaluation. Nothing too spectacular is happening here. CGBD is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CGBD was profitable.
In the past year CGBD has reported a negative cash flow from operations.
CGBD had positive earnings in each of the past 5 years.
CGBD had a positive operating cash flow in each of the past 5 years.
CGBD Yearly Net Income VS EBIT VS OCF VS FCFCGBD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of 2.82%, CGBD is in line with its industry, outperforming 52.94% of the companies in the same industry.
The Return On Equity of CGBD (6.06%) is comparable to the rest of the industry.
CGBD has a Return On Invested Capital (3.22%) which is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for CGBD is below the industry average of 6.96%.
Industry RankSector Rank
ROA 2.82%
ROE 6.06%
ROIC 3.22%
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.37%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
CGBD Yearly ROA, ROE, ROICCGBD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CGBD has a Profit Margin of 29.49%. This is in the better half of the industry: CGBD outperforms 74.37% of its industry peers.
In the last couple of years the Profit Margin of CGBD has grown nicely.
CGBD's Operating Margin of 41.53% is fine compared to the rest of the industry. CGBD outperforms 75.63% of its industry peers.
In the last couple of years the Operating Margin of CGBD has remained more or less at the same level.
CGBD has a Gross Margin (44.34%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CGBD has remained more or less at the same level.
Industry RankSector Rank
OM 41.53%
PM (TTM) 29.49%
GM 44.34%
OM growth 3Y-3.76%
OM growth 5Y-1.44%
PM growth 3Y-26.26%
PM growth 5Y5.82%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
CGBD Yearly Profit, Operating, Gross MarginsCGBD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

4

2. Health

2.1 Basic Checks

The number of shares outstanding for CGBD has been increased compared to 1 year ago.
The number of shares outstanding for CGBD has been reduced compared to 5 years ago.
CGBD has a better debt/assets ratio than last year.
CGBD Yearly Shares OutstandingCGBD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CGBD Yearly Total Debt VS Total AssetsCGBD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

CGBD has an Altman-Z score of 0.56. This is a bad value and indicates that CGBD is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.56, CGBD is doing worse than 60.50% of the companies in the same industry.
CGBD has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of CGBD (1.10) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 0.56
ROIC/WACCN/A
WACCN/A
CGBD Yearly LT Debt VS Equity VS FCFCGBD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

CGBD has a Current Ratio of 2.31. This indicates that CGBD is financially healthy and has no problem in meeting its short term obligations.
CGBD has a better Current ratio (2.31) than 76.89% of its industry peers.
A Quick Ratio of 2.31 indicates that CGBD has no problem at all paying its short term obligations.
CGBD has a Quick ratio of 2.31. This is in the better half of the industry: CGBD outperforms 76.89% of its industry peers.
Industry RankSector Rank
Current Ratio 2.31
Quick Ratio 2.31
CGBD Yearly Current Assets VS Current LiabilitesCGBD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

3

3. Growth

3.1 Past

CGBD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.05%.
CGBD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.24% yearly.
Looking at the last year, CGBD shows a small growth in Revenue. The Revenue has grown by 2.55% in the last year.
CGBD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)-21.05%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-22.45%
Revenue 1Y (TTM)2.55%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%13.59%

3.2 Future

Based on estimates for the next years, CGBD will show a decrease in Earnings Per Share. The EPS will decrease by -7.24% on average per year.
Based on estimates for the next years, CGBD will show a small growth in Revenue. The Revenue will grow by 5.05% on average per year.
EPS Next Y-19%
EPS Next 2Y-10.56%
EPS Next 3Y-7.24%
EPS Next 5YN/A
Revenue Next Year13.44%
Revenue Next 2Y9.5%
Revenue Next 3Y5.05%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CGBD Yearly Revenue VS EstimatesCGBD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
CGBD Yearly EPS VS EstimatesCGBD Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

5

4. Valuation

4.1 Price/Earnings Ratio

CGBD is valuated cheaply with a Price/Earnings ratio of 7.61.
84.03% of the companies in the same industry are more expensive than CGBD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CGBD to the average of the S&P500 Index (26.11), we can say CGBD is valued rather cheaply.
With a Price/Forward Earnings ratio of 7.84, the valuation of CGBD can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CGBD indicates a rather cheap valuation: CGBD is cheaper than 84.45% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.21. CGBD is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 7.61
Fwd PE 7.84
CGBD Price Earnings VS Forward Price EarningsCGBD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CGBD Per share dataCGBD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A cheap valuation may be justified as CGBD's earnings are expected to decrease with -7.24% in the coming years.
PEG (NY)N/A
PEG (5Y)3.39
EPS Next 2Y-10.56%
EPS Next 3Y-7.24%

5

5. Dividend

5.1 Amount

CGBD has a Yearly Dividend Yield of 12.77%, which is a nice return.
Compared to an average industry Dividend Yield of 8.39, CGBD pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.32, CGBD pays a better dividend.
Industry RankSector Rank
Dividend Yield 12.77%

5.2 History

The dividend of CGBD has a limited annual growth rate of 1.13%.
CGBD has been paying a dividend for over 5 years, so it has already some track record.
CGBD has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)1.13%
Div Incr Years4
Div Non Decr Years4
CGBD Yearly Dividends per shareCGBD Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

136.52% of the earnings are spent on dividend by CGBD. This is not a sustainable payout ratio.
CGBD's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP136.52%
EPS Next 2Y-10.56%
EPS Next 3Y-7.24%
CGBD Yearly Income VS Free CF VS DividendCGBD Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
CGBD Dividend Payout.CGBD Dividend Payout, showing the Payout Ratio.CGBD Dividend Payout.PayoutRetained Earnings

CARLYLE SECURED LENDING INC

NASDAQ:CGBD (12/1/2025, 8:00:00 PM)

After market: 12.55 0 (0%)

12.55

-0.1 (-0.79%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-04 2025-11-04/amc
Earnings (Next)02-23 2026-02-23/amc
Inst Owners36%
Inst Owner Change-0.53%
Ins Owners0.42%
Ins Owner Change0.66%
Market Cap914.89M
Revenue(TTM)245.01M
Net Income(TTM)72.24M
Analysts51.67
Price Target13.62 (8.53%)
Short Float %0.94%
Short Ratio1.13
Dividend
Industry RankSector Rank
Dividend Yield 12.77%
Yearly Dividend1.89
Dividend Growth(5Y)1.13%
DP136.52%
Div Incr Years4
Div Non Decr Years4
Ex-Date12-31 2025-12-31 (0.4)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-4.11%
Min EPS beat(2)-5.68%
Max EPS beat(2)-2.53%
EPS beat(4)1
Avg EPS beat(4)-2.64%
Min EPS beat(4)-7.06%
Max EPS beat(4)4.72%
EPS beat(8)3
Avg EPS beat(8)-0.78%
EPS beat(12)6
Avg EPS beat(12)-0.15%
EPS beat(16)9
Avg EPS beat(16)3.56%
Revenue beat(2)0
Avg Revenue beat(2)-6.75%
Min Revenue beat(2)-10.46%
Max Revenue beat(2)-3.03%
Revenue beat(4)1
Avg Revenue beat(4)-5.25%
Min Revenue beat(4)-10.46%
Max Revenue beat(4)0.28%
Revenue beat(8)3
Avg Revenue beat(8)-3.15%
Revenue beat(12)4
Avg Revenue beat(12)-2.52%
Revenue beat(16)7
Avg Revenue beat(16)0.02%
PT rev (1m)-7.56%
PT rev (3m)-7.56%
EPS NQ rev (1m)-6.78%
EPS NQ rev (3m)-6.67%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.27%
Revenue NQ rev (1m)-1.98%
Revenue NQ rev (3m)0.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.36%
Valuation
Industry RankSector Rank
PE 7.61
Fwd PE 7.84
P/S 3.73
P/FCF N/A
P/OCF N/A
P/B 0.77
P/tB 0.77
EV/EBITDA N/A
EPS(TTM)1.65
EY13.15%
EPS(NY)1.6
Fwd EY12.75%
FCF(TTM)-2.23
FCFYN/A
OCF(TTM)-2.23
OCFYN/A
SpS3.36
BVpS16.36
TBVpS16.36
PEG (NY)N/A
PEG (5Y)3.39
Graham Number24.64
Profitability
Industry RankSector Rank
ROA 2.82%
ROE 6.06%
ROCE 4.07%
ROIC 3.22%
ROICexc 3.28%
ROICexgc 3.29%
OM 41.53%
PM (TTM) 29.49%
GM 44.34%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.2%
ROE(3y)9.37%
ROE(5y)9.03%
ROIC(3y)4.38%
ROIC(5y)4.06%
ROICexc(3y)4.5%
ROICexc(5y)4.2%
ROICexgc(3y)4.5%
ROICexgc(5y)4.2%
ROCE(3y)5.55%
ROCE(5y)5.14%
ROICexgc growth 3Y8.24%
ROICexgc growth 5Y2.47%
ROICexc growth 3Y8.2%
ROICexc growth 5Y2.45%
OM growth 3Y-3.76%
OM growth 5Y-1.44%
PM growth 3Y-26.26%
PM growth 5Y5.82%
GM growth 3Y-3.2%
GM growth 5Y-0.67%
F-Score2
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.26
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.31
Quick Ratio 2.31
Altman-Z 0.56
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)133.13%
Profit Quality(5y)1416.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.05%
EPS 3Y9.58%
EPS 5Y2.24%
EPS Q2Q%-22.45%
EPS Next Y-19%
EPS Next 2Y-10.56%
EPS Next 3Y-7.24%
EPS Next 5YN/A
Revenue 1Y (TTM)2.55%
Revenue growth 3Y10.75%
Revenue growth 5Y1%
Sales Q2Q%13.59%
Revenue Next Year13.44%
Revenue Next 2Y9.5%
Revenue Next 3Y5.05%
Revenue Next 5YN/A
EBIT growth 1Y-6.64%
EBIT growth 3Y6.6%
EBIT growth 5Y-0.46%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-204.93%
FCF growth 3Y11.41%
FCF growth 5YN/A
OCF growth 1Y-204.93%
OCF growth 3Y11.41%
OCF growth 5YN/A

CARLYLE SECURED LENDING INC / CGBD FAQ

What is the ChartMill fundamental rating of CARLYLE SECURED LENDING INC (CGBD) stock?

ChartMill assigns a fundamental rating of 4 / 10 to CGBD.


What is the valuation status for CGBD stock?

ChartMill assigns a valuation rating of 5 / 10 to CARLYLE SECURED LENDING INC (CGBD). This can be considered as Fairly Valued.


What is the profitability of CGBD stock?

CARLYLE SECURED LENDING INC (CGBD) has a profitability rating of 5 / 10.


How financially healthy is CARLYLE SECURED LENDING INC?

The financial health rating of CARLYLE SECURED LENDING INC (CGBD) is 4 / 10.


How sustainable is the dividend of CARLYLE SECURED LENDING INC (CGBD) stock?

The dividend rating of CARLYLE SECURED LENDING INC (CGBD) is 5 / 10 and the dividend payout ratio is 136.52%.